All News

@Rhemnow #ACR20 abs0307 analysis of PsA pts diagnostic pathway emphasizes difference in Dx coding by specialty (Derm unlikely to code arthritis, rheum unlikely to code PSO, PCP tend to code general MSK and axial symptoms). PSO and enthesitis codes increased closer to PsA Dx https://t.co/i6ZmjlD3xs
Olga Petryna DrPetryna ( View Tweet)
ACHILLES study: Only 56% of pts w/ clinical enthesitis had MRI+ heel enthesitis. MRI screening: HLAB27+ pts likely to be in MRI+ grp. @RheumNow #ACR20 Abstr#0447 #ACRbest https://t.co/m2cjDzYfyg
sheila RHEUMarampa ( View Tweet)
More UPA safety studies Abst#0215 shows balanced VTE event rates across UPA doses and comparator groups. Evidence for Dr. Strand to use in #ACR20 Great Debate that VTE may be safe TNF alternative @RheumNow. https://t.co/hByttIxiuX
Eric Dein ejdein1 ( View Tweet)
“Immunology is the cornerstone of medicine and we are the experts.” #ACR20 president, Dr. Ellen Gravallese @RheumNow

Dr. Rachel Tate uptoTate ( View Tweet)

Sustained DMARD-free remission (SFDR) seen in ACPA- RA pts; DAS levels at 4mos. predictive for SFDR. ACPA+ pts no relation w/ SFDR & DAS course @RheumNow #ACR20 Abstr#479 #ACRbest https://t.co/kko4tO7s1Y
sheila RHEUMarampa ( View Tweet)
Small study showed poor to fair agreement of PE and US findings of hands in PsA. Do you use US in your clinic for diagnostics? #ABS0314 @RheumNow #ACR20 https://t.co/6oQG4SB1d3 https://t.co/SQK7uhX02T

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
JAKs are no longer new, Winthrop et al presents 8.4 year BARI data in Abst#0202 at #ACR20. VTE risk stable over time, again shows reason to vaccinate patients for zoster before starting. @RheumNow https://t.co/OSIvHl2f7Y
Eric Dein ejdein1 ( View Tweet)
Beautiful poster and fascinating research from @chriswincup et al showing immune cellular iron deficiency in patients with #SLE. Time to add iron supplementation as part of standard #lupus therapy? https://t.co/Uf81KXbSM0 Abs#0294 #ACR20 @RheumNow https://t.co/z5SUjWFkdD

Links:

Mrinalini Dey DrMiniDey ( View Tweet)
Abst#0181 out of Korea shows MTX use does not increase prevalence of hepatic steatosis. Encouraging data, though retrospective study may underpin provider bias in riskier patients. #ACR20 @RheumNow. https://t.co/HeR5hroYUh
Eric Dein ejdein1 ( View Tweet)
ANA antibodies in longitudinal #SLE cohort: - 759 patients - 84.8% remained ANA+ve during 5yr followup period - Pts w/ at least one -ve ANA in first 5yrs had milder disease (lower SLEDAI-2K, less steroid, fewer autoantibodies) Abs#0251 #ACR20 @RheumNow https://t.co/U7JbNpJA3w

Links:

Mrinalini Dey DrMiniDey ( View Tweet)

Large data from Japanese Ninja database in abst#0183 shows incidence of malignancies in Japanese RA patients similar to Japanese gen pop. Comparable in patients exposed and unexposed to biologics/JAKs. #ACR20 @RheumNow

Eric Dein ejdein1 ( View Tweet)

15 % of Relapsing Polychondritis meet diagnosis for MAGIC syndrome (Mouth and genital ulcers with inflamed cartilage) - overlap of RP and Behcet's Abst#0425 #ACR20 #ACRbest @RheumNow https://t.co/qaHWwOOL7Q
Bella Mehta bella_mehta ( View Tweet)
Great debate by Dr. Weinblatt and Dr. Strand on JAKinibs vs TNFi in RA! How long do you tx with JAKinibs before calling it a failure? @RheumNow #ACR20 #ACRbest

Robert B Chao, MD doctorRBC ( View Tweet)

PMR takes fit patients, and drags them down. In this @HSpecialSurgery cohort, PMR patients were more frail: worse physical function, fatigue, and pain - despite a low comorbidity burden. We need to understand the burden of PMR better. IL-6? @SattuiSEMD #ACR20 ABST0422 @RheumNow https://t.co/j6HLNA7ANv
David Liew drdavidliew ( View Tweet)
Dr. Weinblatt dodges the question which TNFi prefers after MTX-IR. Which one do you choose? #ACR20 #GreatDebate @RheumNow

k dao KDAO2011 ( View Tweet)

Dr.Gonzalez-Mazon describes surrogate markers assoc'd w #atherosclerosis in #axSpA: BASFI, BASMI, IBD, ESR, CRP, prednisone and DMARDs use. @RheumNow #ACR20 abst#0448 https://t.co/g27qA4qpPL
sheila RHEUMarampa ( View Tweet)
Abst#0135 at #ACR20 illustrates the drivers of patient satisfaction per a survey of 374 U.S. pts. The biggest obstacles to managing RA are pain (80%), fatigue (72%), & depression/anxiety (51%), but only 51% of pts feel that these are addressed. @RheumNow https://t.co/I2ac2T2TOA
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
The GRA now have >17,000 pts registered! Watch the video link @rheumnow or YouTube: https://t.co/tdp5q7tAPK Please visit the GRA booth @rheum_cat @JYazdanyMD @philipcrobinson @rheum_covid #ACR20 https://t.co/UObvGO3n9Q

Links:

k dao KDAO2011 ( View Tweet)

Agreed- hence the debate is more about patient preference and we need to equip patients with enough information to make correct choices for themselves! @ACRheum @RheumNow #ACR20 https://t.co/zp8HX0YPBV

Links:

alexa meara lexmeara ( View Tweet)

Where one lives matters! Especially during the #COVID19 "flares" - Geographical variations in risk perception and medication management by rheumatologists vary by #COVID19 case burden in the community. Check our abst#0005 #ACR20 @RheumNow

Bella Mehta bella_mehta ( View Tweet)

×